Elmiron (pentosan Polysulfate Sodium) And The Risk Of Pigmentary Maculopathy

Elmiron Recall Summary Elmiron (pentosan polysulfate sodium), a medication used to treat bladder pain, is being recalled in Canada because it may cause pigmentary maculopathy, a condition affecting the macula (the central part of the retina in the eye). This eye condition can develop in patients who have taken the drug over an extended period. The recall affects all Elmiron products distributed across Canada.

Reason

Product safety

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2020-12-15

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/0cd6f10a-e7df-4ad1-9843-910932bd28f7